Background
Microbiology
- Caused by Salmonella enterica subsp. typii and paratyphii
- Virulence is related to Vi antigen and invasin protein
Epidemiology
- Fecal-oral transmission acquired from contaminated food, milk, or water
- Less than 5% of infected people become chronic carriers, with bacteria remaining in the gallbladder despite adequate antibiotic treatment
Pathophysiology
- Induction of pH-shock proteins and other adaptions allow ingested bacteria to pass through the stomch and into the small intestine
- There, they penetrate the intestinal mucosa followed by mononuclear cells, which transport them to lypmh nodes
- They multiple within the reticuloendothelial system during the incubation period
- After a threshold is reached, they disseminate to blood
Clinical Manifestations
Diagnosis
- Blood cultures (large volume, like x4), stool cultures, bone marrow
- Biopsy (most sensitive)
Management
- Treatment with third-generation cephalosporins like ceftriaxone, stepped down to oral when improving and susceptibility data are available
- Duration 10 to 14 days
- Can take 4 to 6 days to defervesce, even with treatment
- Monitor for relapse 2 to 3 weeks after treatment ends